BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15245776)

  • 1. DT-diaphorase: a target for new anticancer drugs.
    Danson S; Ward TH; Butler J; Ranson M
    Cancer Treat Rev; 2004 Aug; 30(5):437-49. PubMed ID: 15245776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development.
    Phillips RM; Burger AM; Loadman PM; Jarrett CM; Swaine DJ; Fiebig HH
    Cancer Res; 2000 Nov; 60(22):6384-90. PubMed ID: 11103802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
    Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DT-diaphorase as a target enzyme for biochemical modulation of mitomycin C.
    Saeki S; Nishiyama M; Toge T
    Hiroshima J Med Sci; 1995 Sep; 44(3):55-63. PubMed ID: 8567314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DT-diaphorase].
    Mikami K; Shirakusa T; Tsuruo T
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1606-10. PubMed ID: 9309161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors.
    Gan Y; Mo Y; Kalns JE; Lu J; Danenberg K; Danenberg P; Wientjes MG; Au JL
    Clin Cancer Res; 2001 May; 7(5):1313-9. PubMed ID: 11350900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin C resistance induced by TCF-3 overexpression in gastric cancer cell line MKN28 is associated with DT-diaphorase down-regulation.
    Sagara N; Katoh M
    Cancer Res; 2000 Nov; 60(21):5959-62. PubMed ID: 11085512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł.
    Malkinson AM; Siegel D; Forrest GL; Gazdar AF; Oie HK; Chan DC; Bunn PA; Mabry M; Dykes DJ; Harrison SD
    Cancer Res; 1992 Sep; 52(17):4752-7. PubMed ID: 1324793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
    Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
    Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase.
    Wang X; Doherty GP; Leith MK; Curphey TJ; Begleiter A
    Br J Cancer; 1999 Jun; 80(8):1223-30. PubMed ID: 10376975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines.
    Mikami K; Naito M; Tomida A; Yamada M; Sirakusa T; Tsuruo T
    Cancer Res; 1996 Jun; 56(12):2823-6. PubMed ID: 8665520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase.
    Workman P
    Oncol Res; 1994; 6(10-11):461-75. PubMed ID: 7620214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the prodrug-activating enzyme DT-diaphorase via Ad5 delivery to human colon carcinoma cells in vitro.
    Misra V; Klamut HJ; Rauth AM
    Cancer Gene Ther; 2002 Feb; 9(2):209-17. PubMed ID: 11857040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies.
    Ross D; Beall H; Traver RD; Siegel D; Phillips RM; Gibson NW
    Oncol Res; 1994; 6(10-11):493-500. PubMed ID: 7620217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of DT-diaphorase in cancer chemoprevention and chemotherapy.
    Begleiter A; Leith MK; Curphey TJ; Doherty GP
    Oncol Res; 1997; 9(6-7):371-82. PubMed ID: 9406243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation.
    Sakamoto N; Toge T; Nishiyama M
    Hiroshima J Med Sci; 1997 Jun; 46(2):67-73. PubMed ID: 9232934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of NQO1 induction on the antitumor activity of RH1 in human tumors in vitro and in vivo.
    Digby T; Leith MK; Thliveris JA; Begleiter A
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):307-16. PubMed ID: 15877230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of DT-diaphorase in transfected NIH 3T3 cells does not lead to increased anticancer quinone drug sensitivity: a questionable role for the enzyme as a target for bioreductively activated anticancer drugs.
    Powis G; Gasdaska PY; Gallegos A; Sherrill K; Goodman D
    Anticancer Res; 1995; 15(4):1141-5. PubMed ID: 7653992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
    Beall HD; Mulcahy RT; Siegel D; Traver RD; Gibson NW; Ross D
    Cancer Res; 1994 Jun; 54(12):3196-201. PubMed ID: 8205540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.